Navigation Links
Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies

Study Reveals that Thoracic Endoluminal Grafting is a Feasible Alternative

TO Open Surgical Repair J Vasc Surg. 2007 Sep; 46(3):413-20. Application of Endograft to Treat Thoracic Aortic Pathologies: A Single Center Experience. Rodriguez JA, Olsen DM, Shtutman A, Lucas LA, Wheatley G, Alpern J, Ramaiah V, Diethrich


PHOENIX, Sept. 28 /PRNewswire/ -- The Arizona Heart Institute announced today that results from its single-center study of the effectiveness of endoluminal grafting for thoracic aortic pathologies were published in the September 2007 issue of the Journal of Vascular Surgery. Presented in the leading subspecialty, peer-reviewed journal in the field of vascular surgery, the study showed that patients with potentially life-threatening conditions of the thoracic aorta, including thoracic aortic aneurysms, can be treated effectively using a less invasive method associated with minimal blood loss, faster recovery, shorter hospital stays and decreased risk of death.

To view the Multimedia News Release, go to:

"This study represents a significant milestone in managing complex conditions of the thoracic aorta," reported Julio A. Rodriquez-Lopez, M.D., lead author and medical director of Peripheral Vascular Services at the Arizona Heart Institute. "In our research findings and overall experience with thoracic endoluminal graft (ELG) repair, we see a significantly less overall complication rate, including death, compared to published adverse events associated with open surgical repair," continued Rodriguez. "This is greatly due to the minimally invasive nature of the technique as well as our ability to proactively treat patients with elective, non-emergent procedures earlier in the disease process."

Thoracic aortic aneurysm, or "bulging" of the major artery which arises from the heart, is a serious condition prone to rupture and sudden death. According to the Society for Vascular Surgery, less than half of all patients who experience a rupture of a thoracic aortic die before reaching the hospital, making it the 13th leading cause of death in the U.S. Furthermore, studies report that emergent, open surgical repair of a ruptured thoracic aneurysm carries a 25 to 50 percent risk of death. ELGs, which are metal stents covered by a fabric graft material, offer a lower-risk alternative to open surgical repair. The device is delivered under X-ray guidance via a catheter passed through an artery near the groin. The ELG is then positioned and expanded within the aorta at the site of the problem, restoring blood flow, providing significant pain relief and reducing the risk of rupture. Depending on their general condition, patients typically return home within a few days.

"It is evident that ELGs represent an important means of treating thoracic aortic pathologies," said Venkatesh G. Ramaiah, M.D., study co-author and director of Peripheral Vascular and Endovascular Research at the Arizona Heart Institute. "To date, this is the largest published series of patients treated with thoracic ELGs for a variety of thoracic aortic pathologies. After more than 500 cases performed at the Arizona Heart Institute, complication rates, including death, compare favorably with open surgical repair, suggesting that endoluminal grafting is a favorable alternative in the treatment of thoracic aortic pathologies," said Ramaiah.

"We are very pleased with the results from this important study which further supports the movement toward minimally invasive management of aortic disease," said Edward B. Diethrich, M.D., medical director, founder of the Arizona Heart Institute and study author. "Since the early 1990s, we have pioneered a multitude of new technologies, treatments and therapies for cardiovascular disease. Clearly, the institution of endoluminal grafting represents a hallmark in the changing treatment paradigm for patients with potentially lethal and debilitating diseases of the thoracic aorta. Our team looks forward to continued research and scientific endeavors to hopefully, in the future, make inroads in the prevention of all cardiovascular diseases," continued Diethrich.

Study Details

From March 1998 to March 2006, repair of the thoracic aorta using an ELG was performed on 406 patients at the Arizona Heart Institute, including 324 patients receiving a commercially available FDA-approved implant with the remaining patients receiving investigational devices. Patient population included those eligible for open surgical repair and those with prohibitive surgical risk. The majority of treated patients had atherosclerotic aneurysms (157; 48.5%) and one quarter (82; 25.3%) had type B dissections. The remaining patients were treated for thoracic aortic pathologies including penetrating ulcers (34; 10.5%), pseudoaneurysms (26; 8%), transections (11; 3.4%), aorto- bronchial fistulas (9; 2.8%), aorto-esophageal fistulas (1; 0.3%) and embolization (4; 1.2%). One hundred cases (31.5%) were non-elective and 49 (15.1%) were ruptures. All patients received a follow-up evaluation at six months and yearly, with a follow-up range between one and 70 months (average 17 months).

The study results revealed the following:

-- Sac Size (only among aneurysm component): Preoperative aneurysm sac

size ranged from 5 to 12 centimeters, with an average size of 6.3 cm.

Sac shrinkage occurred in 65% (102 of 157) of patients. Average

postoperative sac size of 5.4 cm was noted in a mean follow-up of 20.4


-- Endoleaks: Endoleak, or blood leakage around the ELG, creates

insufficient seal to the aorta wall. Four types of leaks have been

defined and range from type I (the most serious and requiring

correction) to type IV (graft porosity, rarely seen with current

devices). In the study, the occurrence of early endoleaks was low and

included 18 (5.5%) type I, four (1.2%) type II, and two (0.6%) type III


-- Paraplegia: Thoracic ELG repair can cause decreased blood supply to the

spinal cord, leading to paraplegia. In this study, paraplegia occurred

in five (1.5%) patients and paresis (slight or partial paralysis) in

three (0.9%); two of the latter improved and one resolved completely

prior to discharge. Paraplegia remains low as a complication and

expectedly increases with difficult anatomy, specific conditions or

open surgical approach. Associated paraplegia with open repair is

estimated at 4%.

-- Mortality: At short-term follow-up, 18 (5.5%) deaths related to the

underlying thoracic aortic pathology occurred within the first thirty

days of the procedure, including three intraoperative deaths. Late

mortality was 9.6% with 31 deaths unrelated to the procedure or

underlying condition.

-- Complications: The overall complication rate was 22.7%, 14.2% (46) in

elective cases and 8.5% (28) in non-elective cases. The vast majority

of these were minor and easily managed with satisfactory outcomes.

Thoracic Aortic Aneurysms and Related Conditions

The aorta is the largest artery in the human body which carries blood away from the heart, with the thoracic aorta being the portion of the aorta coursing through the chest. When a weak area of the thoracic aorta expands or bulges like a balloon, it is called a thoracic aortic aneurysm (TAA). TAAs are often caused by atherosclerosis, or hardening and weakening of the arteries. An aortic dissection, which is often associated with high blood pressure, occurs when blood flow forces apart and weakens the aortic wall layers, often leading to aneurysmal dilatation. A pseudoaneurysm, also known as a false aneurysm, is an "out pouching" of the aorta involving a defect in the two innermost tissue layers or the aorta. True aneurysms, in contrast, are vascular out pouchings involving all three tissue layers of the aorta. Less common yet serious conditions such as a penetrating ulcer of the aorta or a fistula, which is an abnormal connection or passageway between the aorta and other organs, can cause fatal hemorrhage. Trauma from a fall or motor vehicle accident may cause the thoracic aorta to transect and rupture.

Left untreated, TAAs can burst or rupture, leading to severe internal bleeding, shock and death. Approximately half of all TAAs go undetected because patients do not experience symptoms. Presence of symptoms may depend on the location and size of the aneurysm and whether a dissection is present. Symptoms of aortic rupture or dissection can occur suddenly with severe, sharp pain in the chest or upper back. Patients who experience these symptoms should seek immediate medical attention.

Early detection of aortic aneurysms can prevent sudden death, therefore patients with a family history of aortic aneurysm or other connective tissue disorders should notify their physician about their risk of thoracic aortic aneurysm. Thoracic aneurysms can be easily diagnosed using simple imaging tests including MRI and CT scan. If the TAA is small (around four or less centimeters in diameter), the physician may simply recommend monitoring the size and shape of the aneurysm every six months while also addressing other risk factors such as high blood pressure to reduce the degree of pressure on the weakened area of the aneurysm. Large, symptomatic TAAs require prompt attention to prevent rupture and are typically treated by a vascular surgeon with either open surgical repair or less invasive, endoluminal graft repair as described in this respect.

About the Arizona Heart Institute

Since 1971, the Arizona Heart Institute has been dedicated to the prevention, detection and treatment of cardiac and cardiovascular disorders. Its team of board-certified specialists uses the latest means to diagnose the threat of heart and vascular disease before it strikes. The Arizona Heart Institute performs nearly all diagnostic tests on site, providing patients with the convenience of a complete, same-day analysis on an outpatient basis. Patients requiring interventional procedures such as endoluminal grafting are treated and cared for by our same team of specialists at the Arizona Heart Hospital. For more information, visit the Arizona Heart Institute Website at

Learn More about Thoracic Aortic Aneurysms

Endovascular Treatment of a Descending Thoracic Aortic Aneurysm Dr. Edward B. Diethrich and Dr. Grayson Wheatley Apply New Technology to a Thoracic Aneurysm

Related Links and References

Abstract - Application of endograft to treat thoracic aortic pathologies:

A single center experience

International Society of Endovascular Specialists

International Congress XXI Endovascular Interventions

SOURCE The Arizona Heart Institute
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
2. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
3. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
4. Treating Heart Disease Risk Factors May Slow Alzheimers Disease Progression
5. Pilot Phase 3 Results of NovaCardias KW-3902 for Acute Congestive Heart Failure Presented at Late-Breaking Session of Heart Failure Congress 2007
6. Drug for Treatment of Heart Failure Does Not Improve Survival, Compared to More Widely-used Medication
7. deCODE Announces Positive Topline Results for Phase I Study of DG051 for the Prevention of Heart Attack
8. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
9. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
10. First Controlled Large-Scale Intervention Angiotensin Receptor Blocker (ARB) Trial in a Japanese Population, JIKEI HEART Study Demonstrates Significant Reduction in Blood Pressure and Protection of Organs with Valsartan
11. New Anti-Rejection Medication 6-Month Results for Heart Transplant Recipients to Be Released at International Heart and Lung Transplant Meeting
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... Global Cell Surface Testing Market: Supplier ... to their offering.  --> ... of the  "2016 Future Horizons and ...
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Drug Monitoring (TDM) Market: Supplier Shares, ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/26/2015)... , November 26, 2015 ... of the "Radioimmunoassay Market by Type ... Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application ... Forecast to 2020" report to their ... announced the addition of the "Radioimmunoassay ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... The rapid speed ... As people age, more care is needed, especially with Alzheimer’s, dementia and other ... are being overworked. The forgotten part of this equation: 80 percent of medical ...
(Date:11/27/2015)... ... ... Lizzie’s Lice Pickers just announced a special promotion that will run throughout ... of lice treatment product. In addition, customers will receive a complimentary head Check when ... is a sure way to ruin the holidays, so we encourage all of our ...
(Date:11/27/2015)... Fairfax, VVA (PRWEB) , ... November 27, 2015 ... ... (RBMA) motto of progress through sharing, the 2016 Building Better Radiology ... campaigns. The conference will begin on Sunday, March 6, 2016, at Caesars Palace ...
(Date:11/27/2015)... Bangalore, Karnataka (PRWEB) , ... November 27, 2015 ... ... the world, Health-E-minds, an innovative online platform for mental health and wellness consultation, ... KleverKid. , This partnership will bridge the knowledge gap experienced by parents and ...
(Date:11/27/2015)... ... November 27, 2015 , ... Avid collector, Andrew Hawley ... Michigan boxing style concert posters. This is one of Joplin's most famous and beautiful ... at the University of Michigan in Ann Arbor. The According to Hawley, "It is ...
Breaking Medicine News(10 mins):